SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-021061
Filing Date
2024-04-22
Accepted
2024-04-22 17:00:43
Documents
6
Period of Report
2024-05-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20017192x2_def14a.htm DEF 14A 805480
2 logo_atai.jpg GRAPHIC 43339
3 ny20017192x2_pc01.jpg GRAPHIC 690289
4 ny20017192x2_pc02.jpg GRAPHIC 900953
5 sig_cangermayer.jpg GRAPHIC 13679
6 sig_fbrand.jpg GRAPHIC 12347
  Complete submission text file 0001140361-24-021061.txt   3092503
Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40493 | Film No.: 24861881
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)